Stay updated on Galinpepimut-S vs. Best Available Therapy in AML Maintenance Clinical Trial
Sign up to get notified when there's something new on the Galinpepimut-S vs. Best Available Therapy in AML Maintenance Clinical Trial page.

Latest updates to the Galinpepimut-S vs. Best Available Therapy in AML Maintenance Clinical Trial page
- Check3 days agoChange DetectedThe history now shows a new revision labeled Revision: v3.6.6, superseding Revision: v3.6.5, representing an update to the page's versioning record.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe study history now shows revision v3.6.5, replacing the previous v3.6.4. This represents a small update to the page's revision history rather than any change to core content.SummaryDifference0.1%

- Check39 days agoChange DetectedThe footer revision label was updated from v3.6.3 to v3.6.4, signaling a new build of the site. This change does not alter study records, content, or user interactions.SummaryDifference0.1%

- Check60 days agoChange DetectedThe record history now displays the latest revision entry 'Revision: v3.6.3' replacing the previous 'Revision: v3.6.1'. This marks an update to the study record's release history in the page's versioning log.SummaryDifference0.1%

- Check67 days agoChange Detected- A new revision entry 'Revision: v3.6.1' was added to the record history, replacing the previous 'Revision: v3.6.0' entry. This indicates a minor maintenance/version update to the page's history display.SummaryDifference0.1%

- Check75 days agoChange DetectedThe study's recruitment status changed to no longer looking for participants, indicating enrollment has ceased. The record history shows a new revision tag v3.6.0 and the removal of the previous revision v3.5.5.SummaryDifference0.4%

Stay in the know with updates to Galinpepimut-S vs. Best Available Therapy in AML Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S vs. Best Available Therapy in AML Maintenance Clinical Trial page.